Planning better to save more lives

TL;DR

Well-designed National Cancer Control Plans (PNCC) can significantly reduce cancer mortality and improve quality of life.
Investment in early detection and treatment strategies can yield a return of $2 to $7 for every dollar invested, preventing over 12% of global cancer deaths.
Many countries lack comprehensive budgets, robust data, or sufficient diagnostic infrastructure to effectively implement their cancer control plans.
Latin America faces deep disparities in access, funding, and quality of care, limiting its ability to benefit from innovations like precision medicine.
Strengthening PNCC, investing in reliable data, modernizing health infrastructure, and ensuring equitable access to innovation are key solutions.
Collaboration between governments, academia, the private sector, patient organizations, and multilateral bodies is essential.
Colombia needs to fully develop its cancer regulatory framework to ensure comprehensive care, including early detection, timely diagnosis and treatment, updated clinical practice guidelines, and access to new technologies.
A person-centered approach to cancer care, recognizing individuals beyond their disease, leads to better health outcomes.
Precision medicine contributes to oncology science and patient quality of life.
Transforming innovation into funded, sustainable, and patient-centered public policies is vital for the future of cancer control.

Continuar leyendo el artículo original